Brief: Black Diamond Therapeutics Says BDTX-1535 Generally Well Tolerated, Consistent With Prior Disclosures And No New Safety Signals Observed
13/12/2023 12:26
Dec 13 (Reuters) - Black Diamond Therapeutics Inc
BDTX.O :
* BLACK DIAMOND THERAPEUTICS INC: BDTX-1535 GENERALLY WELL
TOLERATED, CONSISTENT WITH PRIOR DISCLOSURES AND NO NEW SAFETY
SIGNALS OBSERVED
Source text for Eikon: ID:nGNX4YHy6D
Further company coverage: BDTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Black Diamond Therapeutics
See all newsBlack Diamond Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Black Diamond Therapeutics Q2 net loss narrows year over year
Black Diamond Therapeutics Inc expected to post a loss of 20 cents a share - Earnings Preview
Black Diamond Therapeutics Q4 net loss narrows, full-year profit turns positive
U.S. STOCKS ON THE MOVE-Spirit AeroSystems, Boeing, Roblox